Literature DB >> 2777206

Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study.

J W Greve1, D J Gouma, W A Buurman.   

Abstract

Endotoxins play an important role in the pathogenesis of complications of surgery in obstructive jaundice. Preoperative treatment with orally administered deoxycholic acid prevented endotoxin-related complications, such as renal malfunction. Other bile acids, however, were less effective, and the mechanism of action is not known. Endotoxin toxicity is considered to be largely mediated by tumor necrosis factor/cachectin, a cytokine release by mononucler phagocytes. Therefore, we studied the influence of different bile acids on endotoxin-induced tumor necrosis factor production by monocytes in vitro. Bile acids inhibit tumor necrosis factor production through a direct inhibitory effect on the monocytes. Deoxycholic acid was the most effective, chenodeoxycholic acid was less effective and ursodeoxycholic acid was ineffective in the concentrations used. Bile acids did not inactivate endotoxin as measured in a chromogenic Limulus amebocyte lysate assay. The therapeutic effect of bile acids in obstructive jaundice can be explained by an inhibition of endotoxin-induced tumor necrosis factor release by mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777206     DOI: 10.1002/hep.1840100409

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  Surgical correction of gastroesophageal reflux in lung transplant patients is associated with decreased effector CD8 cells in lung lavages: a case series.

Authors:  David C Neujahr; Aminu Mohammed; Onome Ulukpo; Seth D Force; Allan M Ramirez; Andres Pelaez; E Clinton Lawrence; Christian P Larsen; Allan D Kirk
Journal:  Chest       Date:  2010-06-03       Impact factor: 9.410

Review 2.  The bile acid TGR5 membrane receptor: from basic research to clinical application.

Authors:  Henri Duboc; Yvette Taché; Alan F Hofmann
Journal:  Dig Liver Dis       Date:  2014-01-09       Impact factor: 4.088

3.  The effect of oral sodium taurocholate on endotoxemia and intestinal anastomotic wound healing in rats with obstructive jaundice.

Authors:  M Sayan; A Alponat; N Yavuz; E Altinkaya; S Göksel; M Sariyar
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  FXR regulates liver repair after CCl4-induced toxic injury.

Authors:  Zhipeng Meng; Yandong Wang; Lin Wang; Wen Jin; Nian Liu; Hao Pan; Lucy Liu; Lawrence Wagman; Barry M Forman; Wendong Huang
Journal:  Mol Endocrinol       Date:  2010-03-08

5.  Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.

Authors:  Hailiang Liu; Preeti Pathak; Shannon Boehme; John Y L Chiang
Journal:  J Lipid Res       Date:  2016-08-17       Impact factor: 5.922

6.  External biliary drainage plus bile acid feeding is not equal to internal drainage in preserving the cellular immunity following prolonged obstructive jaundice.

Authors:  K T Mok; B W Wang; H C Chang; S L Lin
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

Review 7.  Gastroesophageal reflux disease and graft failure after lung transplantation.

Authors:  Aminu Mohammed; David C Neujahr
Journal:  Transplant Rev (Orlando)       Date:  2010-02-13       Impact factor: 3.943

8.  Effect of biliary drainage on inducible nitric oxide synthase, CD14 and TGR5 expression in obstructive jaundice rats.

Authors:  Zi-Kai Wang; Jian-Guo Xiao; Xue-Fei Huang; Yi-Chun Gong; Wen Li
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 9.  Endocrine and paracrine role of bile acids.

Authors:  Verena Keitel; Ralf Kubitz; Dieter Häussinger
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

10.  Bile acids repress hypoxia-inducible factor 1 signaling and modulate the airway immune response.

Authors:  Claire Legendre; F Jerry Reen; David F Woods; Marlies J Mooij; Claire Adams; Fergal O'Gara
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.